Doebele Robert — SEC Form 4 filings

SEC reporting owner CIK 1856681. 3 Form 4 filings on record with FilingPulse; latest filed 2026-01-26.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-26 to 2026-01-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Rain Oncology Inc. (RAIN)See Remarks113
Boundless Bio, Inc. (BOLD)Chief Medical Officer22

Form 4 filings — Doebele Robert

FiledFormIssuerReported transactionsSource
2026-01-264Boundless Bio, Inc. (BOLD)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2025-02-034Boundless Bio, Inc. (BOLD)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-01-264Rain Oncology Inc. (RAIN)Code (U): 476,827 · Disposition to issuer (D): 11,119 (derivative) · Disposition to issuer (D): 90,620 (derivative) · Disposition to issuer (D): 12,358 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 13,890 (derivative) · +7 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856681 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →